ARNA

Arena Pharmaceuticals, Inc. News Headlines

$4.22
*  
0.27
6.01%
Get ARNA Alerts
*Delayed - data as of Apr. 27, 2015  -  Find a broker to begin trading ARNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By











NASH Series: Novo Nordisk And Cadila Healthcare
4/4/2015 1:30:00 PM - Seeking Alpha


Novo Nordisk Entry Is Bullish For The Anti-Obesity Space
4/2/2015 9:20:00 PM - Seeking Alpha




3 Ways Arena Can Boost Shareholder Value
4/2/2015 1:26:00 PM - Investopedia




Arena - Assessing Belviq In South Korea
3/30/2015 7:57:00 PM - Seeking Alpha


Orexigen Will Make The Obesity Space A Two-Product Race
3/30/2015 2:21:00 PM - Seeking Alpha




Arena Investors Need To Pay Attention To Competition
3/27/2015 7:59:00 AM - Seeking Alpha




Orexigen: Contrave Gathering Momentum
3/23/2015 4:51:00 PM - Seeking Alpha




Arena Pharmaceuticals Could Have Better Luck In Quarter 2
3/23/2015 8:49:00 AM - Seeking Alpha


Vivus: Qsymia Sales Slip, Company Needs To Shift Into Gear
3/23/2015 6:51:00 AM - Seeking Alpha